Buscar
Forian Inc
FORAAñadir a la lista de seguimiento
2.170USD
0.0000.00%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
64.01MCap. mercado
PérdidaP/E TTM
Más Datos de Forian Inc Compañía
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
Información de Forian Inc
Símbolo de cotizaciónFORA
Nombre de la empresaForian Inc
Fecha de salida a bolsaMar 03, 2021
Director ejecutivoWygod (Max)
Número de empleados1
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 03
Dirección41 University Drive
CiudadNEWTOWN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal18940
Teléfono12677578707
Sitio Webhttps://forian.com/
Símbolo de cotizaciónFORA
Fecha de salida a bolsaMar 03, 2021
Director ejecutivoWygod (Max)
Ejecutivos de Forian Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Shahir Kassam-Adams
Mr. Shahir Kassam-Adams
Independent Director
Independent Director
174.93K
--
Dr. Mark J. Adler, M.D.
Dr. Mark J. Adler, M.D.
Independent Director
Independent Director
36.33K
--
Ms. Jennifer Hajj
Ms. Jennifer Hajj
Independent Director
Independent Director
10.00K
--
Ms. Alyssa F. Varadhan
Ms. Alyssa F. Varadhan
Independent Director
Independent Director
5.00K
--
Mr. Max Wygod
Mr. Max Wygod
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Adam Dublin
Mr. Adam Dublin
Chief Strategy Officer, Director
Chief Strategy Officer, Director
--
--
Mr. Ian G. Banwell
Mr. Ian G. Banwell
Independent Director
Independent Director
--
--
Dr. Kristiina S. Vuori, M.D., Ph.D.
Dr. Kristiina S. Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Michael T. (Mike) Vesey
Mr. Michael T. (Mike) Vesey
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Shahir Kassam-Adams
Mr. Shahir Kassam-Adams
Independent Director
Independent Director
174.93K
--
Dr. Mark J. Adler, M.D.
Dr. Mark J. Adler, M.D.
Independent Director
Independent Director
36.33K
--
Ms. Jennifer Hajj
Ms. Jennifer Hajj
Independent Director
Independent Director
10.00K
--
Ms. Alyssa F. Varadhan
Ms. Alyssa F. Varadhan
Independent Director
Independent Director
5.00K
--
Mr. Max Wygod
Mr. Max Wygod
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Adam Dublin
Mr. Adam Dublin
Chief Strategy Officer, Director
Chief Strategy Officer, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Forian Inc?
Los cinco principales accionistas de Forian Inc son: Mr. Shahir Kassam-Adams
¿Cuántas instituciones poseen acciones de Forian Inc (FORA)?
A fecha de 2026Q1, 59 instituciones poseen acciones de Forian Inc, con un valor de mercado combinado de aproximadamente 4.40M, lo que representa el 14.91% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 382475.00.
¿Cuál es la mayor fuente de ganancias de Forian Inc?
El 2026Q1, el segmento empresarial Healthcare Information generó la ganancia más alta para Forian Inc, ascendiendo a 16.42M y representando el 58.62% de la ganancia total.